Bariatric surgery versus conservative management for morbidly obese patients in Spain: a cost-effectiveness analysis [0.03%]
西班牙病态肥胖症患者的胃绕行手术与保守治疗方法的成本效益分析研究
Raquel Sanchez-Santos,Esther Mariño Padin,Daniel Adam et al.
Raquel Sanchez-Santos et al.
Background: We assessed the cost-effectiveness of bariatric surgery (BS) versus conservative management (CM) for treating morbid obesity in Spain. Methods...
Cost-effectiveness analysis of the use of high-flow oxygen through nasal cannula in intensive care units in NHS England [0.03%]
英国国家医疗服务体系重症监护病房鼻导管高流量吸氧应用的成本效益分析
Emily Eaton Turner,Michelle Jenks
Emily Eaton Turner
Objective: To estimate the cost-effectiveness of Nasal High Flow (NHF) in the intensive care unit (ICU) compared with standard oxygen or non-invasive ventilation (NIV) from a UK NHS perspective. ...
An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward? [0.03%]
对创新定价方案的评估：价格歧视和两部定价是否是前进的道路？
Peter Hertzman,Paul Miller,Keith Tolley
Peter Hertzman
Introduction: With the introduction of new expensive medicines, traditional pricing schemes based on constructs such as price per pill/vial have been challenged. Potential innovative schemes could be either financial-base...
Toward minimally disruptive management of symptomatic endometriosis: reducing low-value care and the burden of treatment [0.03%]
最小程度干扰性管理症状性子宫内膜异位症：减少低价值治疗和治疗负担
Paolo Vercellini,Maria Pina Frattaruolo,Laura Buggio
Paolo Vercellini
Economic evaluation of medical tests at the early phases of development: a systematic review of empirical studies [0.03%]
系统评价：验证开发初期医疗检测的经济效益
Samuel N Frempong,Andrew J Sutton,Clare Davenport et al.
Samuel N Frempong et al.
Introduction: There is little specific guidance on the implementation of cost-effectiveness modelling at the early stage of test development. The aim of this study was to review the literature in this field to examine the...
Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease [0.03%]
降低胆固醇药物治疗的效果比较研究以减少心血管疾病
Dong-Churl Suh,Scott K Griggs,Emmett R Henderson et al.
Dong-Churl Suh et al.
Introduction: The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor is a new treatment option for patients with hypercholesterolemia. The objective of this study was to systematically review the cost-effecti...
Clinical efficacy and economic evaluation of online cognitive behavioral therapy for major depressive disorder: a systematic review and meta-analysis [0.03%]
基于网络的认知行为疗法治疗重度抑郁障碍的临床疗效及经济效益系统评价和meta分析
Elayne Ahern,Stephen Kinsella,Maria Semkovska
Elayne Ahern
Introduction: Leading cause of disability worldwide, depression is the most prevalent mental disorder with growing societal costs. As mental health services demand often outweighs provision, accessible treatment options a...
Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability? [0.03%]
提高卫生服务中离散选择实验的质量：我们如何才能评估其有效性和可靠性？
Ellen M Janssen,Deborah A Marshall,A Brett Hauber et al.
Ellen M Janssen et al.
The recent endorsement of discrete-choice experiments (DCEs) and other stated-preference methods by regulatory and health technology assessment (HTA) agencies has placed a greater focus on demonstrating the validity and reliability of prefe...
Pharmaceutical pricing in Japan: market evidence for rheumatoid arthritis treatment [0.03%]
日本的药物定价以类风湿性关节炎治疗为例证的市场证据
Jörg Mahlich,Isao Kamae,Rosarin Sruamsiri
Jörg Mahlich
Background: Drug price setting is one of the key challenges faced by the Japanese health care system. This study aims to identify the determinants of drug price in Japan using the example of the rheumatoid arthritis (RA) ...
Direct costs for nonsurgical management of Chronic Pancreatitis in a tertiary care teaching hospital [0.03%]
三级医疗教学医院非手术治疗慢性胰腺炎的直接成本
Nagesh Kamat,Ganesh Pai,Surulivel Rajan Mallayasamy et al.
Nagesh Kamat et al.
Background: Chronic pancreatitis (CP) is a leading cause of hospitalization among gastrointestinal diseases resulting in considerable financial burden to patients. However the direct costs for nonsurgical management in CP...